These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 37376675

  • 1. Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy.
    Nigro G, Muselli M, On Behalf Of The Congenital Cytomegalic Disease Collaborating Group.
    Viruses; 2023 Jun 15; 15(6):. PubMed ID: 37376675
    [Abstract] [Full Text] [Related]

  • 2. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
    Blázquez-Gamero D, Galindo Izquierdo A, Del Rosal T, Baquero-Artigao F, Izquierdo Méndez N, Soriano-Ramos M, Rojo Conejo P, González-Tomé MI, García-Burguillo A, Pérez Pérez N, Sánchez V, Ramos-Amador JT, De la Calle M.
    J Matern Fetal Neonatal Med; 2019 Feb 15; 32(4):617-625. PubMed ID: 28978246
    [Abstract] [Full Text] [Related]

  • 3. Describing the Impact of Maternal Hyperimmune Globulin and Valacyclovir on the Outcomes of Cytomegalovirus Infection in Pregnancy: A Systematic Review.
    Fitzpatrick A, Cooper C, Vasilunas N, Ritchie B.
    Clin Infect Dis; 2022 Oct 12; 75(8):1467-1480. PubMed ID: 35438780
    [Abstract] [Full Text] [Related]

  • 4. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
    Nigro G.
    Expert Rev Anti Infect Ther; 2017 Nov 12; 15(11):977-986. PubMed ID: 29072089
    [Abstract] [Full Text] [Related]

  • 5. No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre.
    Chiaie LD, Neuberger P, Vochem M, Lihs A, Karck U, Enders M.
    Arch Gynecol Obstet; 2018 Jun 12; 297(6):1389-1395. PubMed ID: 29404743
    [Abstract] [Full Text] [Related]

  • 6. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.
    Hamilton ST, van Zuylen W, Shand A, Scott GM, Naing Z, Hall B, Craig ME, Rawlinson WD.
    Rev Med Virol; 2014 Nov 12; 24(6):420-33. PubMed ID: 25316174
    [Abstract] [Full Text] [Related]

  • 7. New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus.
    Egloff C, Sibiude J, Vauloup-Fellous C, Benachi A, Bouthry E, Biquard F, Hawkins-Villarreal A, Houhou-Fidouh N, Mandelbrot L, Vivanti AJ, Picone O.
    Ultrasound Obstet Gynecol; 2023 Jan 12; 61(1):59-66. PubMed ID: 35900718
    [Abstract] [Full Text] [Related]

  • 8. Combined treatment with immunoglobulin and valaciclovir in pregnant women with cytomegalovirus infection and high risk of symptomatic fetal disease.
    De la Calle M, Baquero-Artigao F, Rodríguez-Molino P, Cabanes M, Cabrera M, Antolin E, Mellado MJ, Bartha JL.
    J Matern Fetal Neonatal Med; 2022 Aug 12; 35(16):3196-3200. PubMed ID: 32933353
    [Abstract] [Full Text] [Related]

  • 9. High-Dose Cytomegalovirus (CMV) Hyperimmune Globulin and Maternal CMV DNAemia Independently Predict Infant Outcome in Pregnant Women With a Primary CMV Infection.
    Nigro G, Adler SP, Congenital Cytomegalic Disease Collaborating Group.
    Clin Infect Dis; 2020 Sep 12; 71(6):1491-1498. PubMed ID: 31628849
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
    D'Antonio F, Marinceu D, Prasad S, Khalil A.
    Ultrasound Obstet Gynecol; 2023 Apr 12; 61(4):436-444. PubMed ID: 36484439
    [Abstract] [Full Text] [Related]

  • 11. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
    Seidel V, Hackelöer M, Rancourt RC, Henrich W, Siedentopf JP.
    Arch Gynecol Obstet; 2020 Dec 12; 302(6):1353-1359. PubMed ID: 32754858
    [Abstract] [Full Text] [Related]

  • 12. A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.
    Hughes BL, Clifton RG, Rouse DJ, Saade GR, Dinsmoor MJ, Reddy UM, Pass R, Allard D, Mallett G, Fette LM, Gyamfi-Bannerman C, Varner MW, Goodnight WH, Tita ATN, Costantine MM, Swamy GK, Gibbs RS, Chien EK, Chauhan SP, El-Sayed YY, Casey BM, Parry S, Simhan HN, Napolitano PG, Macones GA, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network.
    N Engl J Med; 2021 Jul 29; 385(5):436-444. PubMed ID: 34320288
    [Abstract] [Full Text] [Related]

  • 13. New evidence on prognostic features, prevention and treatment of congenital Cytomegalovirus infection.
    Sebghati M, Khalil A.
    Curr Opin Obstet Gynecol; 2020 Oct 29; 32(5):342-350. PubMed ID: 32739974
    [Abstract] [Full Text] [Related]

  • 14. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
    Buxmann H, Stackelberg OM, Schlößer RL, Enders G, Gonser M, Meyer-Wittkopf M, Hamprecht K, Enders M.
    J Perinat Med; 2012 Mar 27; 40(4):439-46. PubMed ID: 22752777
    [Abstract] [Full Text] [Related]

  • 15. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
    Kagan KO, Enders M, Schampera MS, Baeumel E, Hoopmann M, Geipel A, Berg C, Goelz R, De Catte L, Wallwiener D, Brucker S, Adler SP, Jahn G, Hamprecht K.
    Ultrasound Obstet Gynecol; 2019 Mar 27; 53(3):383-389. PubMed ID: 29947159
    [Abstract] [Full Text] [Related]

  • 16. Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention.
    Naing ZW, Scott GM, Shand A, Hamilton ST, van Zuylen WJ, Basha J, Hall B, Craig ME, Rawlinson WD.
    Aust N Z J Obstet Gynaecol; 2016 Feb 27; 56(1):9-18. PubMed ID: 26391432
    [Abstract] [Full Text] [Related]

  • 17. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight.
    Nigro G, Capretti I, Manganello AM, Best AM, Adler SP.
    J Matern Fetal Neonatal Med; 2015 Jan 27; 28(2):168-71. PubMed ID: 24660895
    [Abstract] [Full Text] [Related]

  • 18. Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection.
    Codaccioni C, Vauloup-Fellous C, Letamendia E, Saada J, Benachi A, Vivanti AJ.
    J Gynecol Obstet Hum Reprod; 2019 Apr 27; 48(4):287-289. PubMed ID: 30634004
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
    Revello MG, Lazzarotto T, Guerra B, Spinillo A, Ferrazzi E, Kustermann A, Guaschino S, Vergani P, Todros T, Frusca T, Arossa A, Furione M, Rognoni V, Rizzo N, Gabrielli L, Klersy C, Gerna G, CHIP Study Group.
    N Engl J Med; 2014 Apr 03; 370(14):1316-26. PubMed ID: 24693891
    [Abstract] [Full Text] [Related]

  • 20. Passive immunization during pregnancy for congenital cytomegalovirus infection.
    Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalovirus Collaborating Group.
    N Engl J Med; 2005 Sep 29; 353(13):1350-62. PubMed ID: 16192480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.